Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Healthcare Plans

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children's health insurance and health care programs; and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.

Revenue projections:

Revenue projections for UNH
Revenue projections for UNH

UNH's revenues are expected to fall below last year's, and this forecast tends to raise concerns among investors. A revenue drop can negatively impact the company's profitability, making investors more cautious about their positions due to the risks of declining financial performance.

Financial Ratios:

currentRatio 0.788000
forwardPE 17.152582
debtToEquity 81.618000
earningsGrowth -0.999000
revenueGrowth 0.123000
grossMargins 0.185260
operatingMargins 0.003360
trailingEps 13.230000
forwardEps 20.670940

UnitedHealth Group Incorporated's Forward PE ratio suggests that the stock is priced appropriately in relation to its earnings. Not being overpriced, it offers room for growth, signaling potential upside for investors looking for a stock with reasonable valuation and growth potential.
UNH's elevated debt-to-equity ratio shows that the company is relying heavily on debt to fund its activities. This high leverage can amplify returns but also heightens financial risks if cash flow becomes constrained.
UNH's low growth in earnings and revenue indicates a potential decline in profits. This suggests that the company could be facing financial challenges, making it harder to sustain its current profit margins.
UNH's negative gross and operating margins suggest that the company is experiencing losses at both the production and operational levels. This could point to inefficiencies or declining demand for its products.
UnitedHealth Group Incorporated's forward EPS exceeding its trailing EPS means the company is expected to be more profitable this year than last. This suggests an upward trend in earnings, with forecasts indicating that UnitedHealth Group Incorporated's financial performance will improve in the current financial year.

Price projections:

Price projections for UNH
Price projections for UNH

The stock price of UNH has frequently been close to the lower end of analysts' projections. This trend indicates potential struggles for the company in achieving the growth anticipated by the market.

Insider Transactions:

Insider Transactions for UNH
Insider Transactions for UNH


2 transactions were made to sell UNH shares, with market price of 328.6999969482422.3 transactions to buy UNH shares were recorded, with market price at 291.42333984375.UnitedHealth Group Incorporated's current price levels have seen more selling than buying, which may indicate potential for further decline. If this trend continues, the stock could experience additional price drops, as selling pressure grows.

Recommendation changes over time:

Recommendations trend for UNH
Recommendations trend for UNH


A recent buy bias from analysts toward UnitedHealth Group Incorporated may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that UnitedHealth Group Incorporated might be an appealing option for those looking to grow their wealth through stock market investments.